[The lupus erythematosus visceralis syndrome].
D004304:Dosage Forms; D006801:Humans; D007049:Iatrogenic Disease; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced*; D010653:Phenylbutazone / Q000009:adverse effects / Q000031:analogs & derivatives*; D013577:Syndrome
D004304:Dosage Forms; D010653:Phenylbutazone
Erythematodes-Visceralis-Syndrom.